Teva appoints new ceo for teva api, its active pharmaceutical ingredients business

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva) today announced the appointment of dr. r. ananthanarayanan (ananth) as ceo of its teva active pharmaceutical ingredients business (teva api). dr. ananth will lead the api business starting november 27, 2023, and will be based out of teva's u.s. headquarters in parsippany, nj. richard francis, teva's president and ceo said: “i am excited to welcome ananth back to teva to lead the teva api business during.
TEVA Ratings Summary
TEVA Quant Ranking